These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11390031)

  • 21. An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
    Jin X; Ogg G; Bonhoeffer S; Safrit J; Vesanen M; Bauer D; Chen D; Cao Y; Demoitie MA; Zhang L; Markowitz M; Nixon D; McMichael A; Ho DD
    Mol Med; 2000 Sep; 6(9):803-9. PubMed ID: 11071274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers.
    Scott-Algara D; Buseyne F; Blanche S; Rouzioux C; Jouanne C; Romagné F; Rivière Y
    J Infect Dis; 2001 Jun; 183(11):1565-73. PubMed ID: 11343205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors.
    Gea-Banacloche JC; Migueles SA; Martino L; Shupert WL; McNeil AC; Sabbaghian MS; Ehler L; Prussin C; Stevens R; Lambert L; Altman J; Hallahan CW; de Quiros JC; Connors M
    J Immunol; 2000 Jul; 165(2):1082-92. PubMed ID: 10878387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection.
    Yu XG; Addo MM; Rosenberg ES; Rodriguez WR; Lee PK; Fitzpatrick CA; Johnston MN; Strick D; Goulder PJ; Walker BD; Altfeld M
    J Virol; 2002 Sep; 76(17):8690-701. PubMed ID: 12163589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
    Larsson M; Jin X; Ramratnam B; Ogg GS; Engelmayer J; Demoitie MA; McMichael AJ; Cox WI; Steinman RM; Nixon D; Bhardwaj N
    AIDS; 1999 May; 13(7):767-77. PubMed ID: 10357375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
    Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM
    Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and function of HIV-specific CD8(+) T cells.
    Migueles SA; Connors M
    Immunol Lett; 2001 Nov; 79(1-2):141-50. PubMed ID: 11595301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Human immunodeficiency virus-1 gag specific CD8+ T cell responses in long-term nonprogressors and acquired immunodeficiency syndrome patients].
    Zhang HW; Qiu ZF; Li TS
    Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):911-4. PubMed ID: 15730736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.
    Rinaldo C; Huang XL; Fan ZF; Ding M; Beltz L; Logar A; Panicali D; Mazzara G; Liebmann J; Cottrill M
    J Virol; 1995 Sep; 69(9):5838-42. PubMed ID: 7637030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.
    Northfield JW; Loo CP; Barbour JD; Spotts G; Hecht FM; Klenerman P; Nixon DF; Michaëlsson J
    J Virol; 2007 Jun; 81(11):5759-65. PubMed ID: 17376902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma.
    van Baarle D; Hovenkamp E; Callan MF; Wolthers KC; Kostense S; Tan LC; Niesters HG; Osterhaus AD; McMichael AJ; van Oers MH; Miedema F
    Blood; 2001 Jul; 98(1):146-55. PubMed ID: 11418474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection.
    Imami N; Pires A; Hardy G; Wilson J; Gazzard B; Gotch F
    J Virol; 2002 Sep; 76(18):9011-23. PubMed ID: 12186885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.
    Ndhlovu ZM; Stampouloglou E; Cesa K; Mavrothalassitis O; Alvino DM; Li JZ; Wilton S; Karel D; Piechocka-Trocha A; Chen H; Pereyra F; Walker BD
    J Virol; 2015 Nov; 89(21):10735-47. PubMed ID: 26269189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance of HIV-specific central and effector memory CD4 and CD8 T cells requires antigen persistence.
    Sester U; Sester M; Köhler H; Pees HW; Gärtner BC; Wain-Hobson S; Bocharov G; Meyerhans A
    AIDS Res Hum Retroviruses; 2007 Apr; 23(4):549-53. PubMed ID: 17451343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors.
    López M; Soriano V; Lozano S; Ballesteros C; Cascajero A; Rodés B; De La Vega E; González-Lahoz J; Benito JM
    AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1185-95. PubMed ID: 18729773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
    Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens.
    Valdez H; Carlson NL; Post AB; Asaad R; Heeger PS; Lederman MM; Lehmann PV; Anthony DD
    AIDS; 2002 May; 16(8):1113-8. PubMed ID: 12004269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial recovery of senescence and differentiation disturbances in CD8
    Eberhard JM; Ahmad F; Hong HS; Bhatnagar N; Keudel P; Schulze Zur Wiesch J; Schmidt RE; Meyer-Olson D
    Clin Exp Immunol; 2016 Nov; 186(2):227-238. PubMed ID: 27377704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.
    Meijerink H; Indrati AR; van Crevel R; Joosten I; Koenen H; van der Ven AJ
    BMC Infect Dis; 2014 Dec; 14():683. PubMed ID: 25495598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.